We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

205 hedge funds and large institutions have $2.2B invested in Amicus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 83 increasing their positions, 51 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

197% more call options, than puts

Call options by funds: $7.67M | Put options by funds: $2.58M

63% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 51

1.67% more ownership

Funds ownership: 105.96% → 107.63% (+1.7%)

3% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 37

0% less funds holding

Funds holding: 206 → 205 (-1)

22% less funds holding in top 10

Funds holding in top 10: 9 → 7 (-2)

35% less capital invested

Capital invested by funds: $3.36B → $2.2B (-$1.16B)

Holders
205
Holders Change
-1
Holders Change %
-0.49%
% of All Funds
4.49%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.15%
New
38
Increased
83
Reduced
51
Closed
37
Calls
$7.67M
Puts
$2.58M
Net Calls
+$5.09M
Net Calls Change
+$3.75M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$41.4M
2
PA
Perceptive Advisors
New York
+$33.6M
3
Primecap Management
Primecap Management
California
+$23.9M
4
BlackRock
BlackRock
New York
+$23.3M
5
State Street
State Street
Massachusetts
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
-$49.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$45.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.1M
4
HCM
Highline Capital Management
New York
-$18.9M
5
Marshall Wace
Marshall Wace
United Kingdom
-$9.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$20.1M – – –
Goldman Sachs
27
Goldman Sachs
New York
$19M +$97K +8,938 +0.4%
BC
28
Boxer Capital
California
$18.6M – – –
NHAS
29
Novo Holdings A/S
Denmark
$18.6M – – –
VOYA Investment Management
30
VOYA Investment Management
Georgia
$18.3M +$5.23M +481,964 +27%
Primecap Management
31
Primecap Management
California
$17.6M +$23.9M +2,197,500 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$17.5M +$464K +42,736 +2%
N
33
Nuveen
North Carolina
$17.3M -$8.66M -797,926 -27%
MWNA
34
Marshall Wace North America
New York
$16.9M -$49.9M -4,598,329 -69%
Bank of America
35
Bank of America
North Carolina
$16.6M +$3.04K +280 +0%
EAM
36
Eventide Asset Management
Massachusetts
$15.6M – – –
CTA
37
Carillon Tower Advisers
Florida
$14.9M – – –
GTC
38
Ghost Tree Capital
New York
$13.7M +$2.77M +255,000 +18%
BNP Paribas Asset Management
39
BNP Paribas Asset Management
France
$13.3M +$224K +20,593 +1%
Charles Schwab
40
Charles Schwab
California
$12.4M +$1.09M +100,139 +7%
RCAMU
41
Rothschild & Co Asset Management US
Connecticut
$12.2M -$175K -16,083 -1%
Renaissance Technologies
42
Renaissance Technologies
New York
$11.8M +$13.2M +1,217,000 +480%
Axa
43
Axa
France
$11.7M +$802K +73,857 +5%
Massachusetts Financial Services
44
Massachusetts Financial Services
Massachusetts
$11.2M +$2.86M +263,719 +23%
Millennium Management
45
Millennium Management
New York
$10.7M +$2.63M +242,659 +22%
Point72 Asset Management
46
Point72 Asset Management
Connecticut
$10.2M -$19.1M -1,758,664 -58%
SIM
47
Spark Investment Management
New York
$9.61M -$3.73M -343,500 -22%
PF
48
Phoenix Financial
Israel
$8.96M +$12.7M +1,171,096 New
Ameriprise
49
Ameriprise
Minnesota
$8.3M +$491K +45,269 +5%
RSCM
50
Rock Springs Capital Management
Maryland
$8.02M – – –
1
2
3 4 5

FOLD Hedge Fund Activity: Q3 2019 in Review

205 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2019, worth a combined $2.2B — down 35% from $3.36B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new FOLD positions and 37 closed out — a net gain of 1 holder — while 83 added to existing stakes and 51 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $41.4M. The largest seller was Marshall Wace North America, cutting an estimated $49.9M.

  • 205 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2019, down from 206 in Q2 2019.
  • Funds reported $2.2B of Amicus Therapeutics stock for Q3 2019, down 35% quarter-over-quarter.
  • 38 funds opened new Amicus Therapeutics positions in Q3 2019 and 37 closed out, a net change of +1 holder.
  • The largest Amicus Therapeutics buyer in Q3 2019 was Morgan Stanley, an estimated $41.4M added.
  • The largest Amicus Therapeutics seller in Q3 2019 was Marshall Wace North America, an estimated $49.9M sold.

Based on aggregated 13F filings for Q3 2019.